Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Luciano

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
International Journal of Cardiology|November 15, 2016
HMGA1 is a novel candidate gene for myocardial infarction susceptibilitySalvatore De Rosa, Eusebio Chiefari, Nadia Salerno, et al.
Critical Reviews in Oncology/Hematology|December 8, 2023
The impact of PARP inhibitors in the whole scenario of ovarian cancer management: A systematic review and network meta-analysisNicoletta Staropoli, Domenico Ciliberto, Francesco Luciano, et al.
Scientific Reports|December 20, 2016
A polymorphism of HMGA1 protects against proliferative diabetic retinopathy by impairing HMGA1-induced VEGFA expressionEusebio Chiefari, Valeria Ventura, Carmelo Capula, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 28, 2024
Identification of ADME genes polymorphic variants linked to trastuzumab-induced cardiotoxicity in breast cancer patients: Case series of mono-institutional experienceNicoletta Staropoli, Francesca Scionti, Valentina Farenza, et al.
Molecular Therapy. Nucleic Acids|March 14, 2022
miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic reviewMaria Teresa Di Martino, Mariamena Arbitrio, Daniele Caracciolo, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
International Journal of Cardiology|November 15, 2016
HMGA1 is a novel candidate gene for myocardial infarction susceptibilitySalvatore De Rosa, Eusebio Chiefari, Nadia Salerno, et al.
Critical Reviews in Oncology/Hematology|December 8, 2023
The impact of PARP inhibitors in the whole scenario of ovarian cancer management: A systematic review and network meta-analysisNicoletta Staropoli, Domenico Ciliberto, Francesco Luciano, et al.
Scientific Reports|December 20, 2016
A polymorphism of HMGA1 protects against proliferative diabetic retinopathy by impairing HMGA1-induced VEGFA expressionEusebio Chiefari, Valeria Ventura, Carmelo Capula, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 28, 2024
Identification of ADME genes polymorphic variants linked to trastuzumab-induced cardiotoxicity in breast cancer patients: Case series of mono-institutional experienceNicoletta Staropoli, Francesca Scionti, Valentina Farenza, et al.
Molecular Therapy. Nucleic Acids|March 14, 2022
miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic reviewMaria Teresa Di Martino, Mariamena Arbitrio, Daniele Caracciolo, et al.
Pageof 3